Inhibition of EphB4 Receptor Signaling by Ephrin-B2-Competitive and Non-Competitive DARPins Prevents Angiogenesis
Biochemistry · 2025
DOI: 10.1021/acs.biochem.4c00431 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry, 2025. Verfasst von Weronika Trun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research and Early Development Oncology, Bayer AG, Müllerstr. 178, Berlin 13342, Germany. Hauptthemen laut MEDLINE: Receptor, EphB4, Ephrin-B2, Signal Transduction, Neovascularization, Pathologic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Research and Early Development Oncology, Bayer AG, Müllerstr. 178, Berlin 13342, Germany.
- Department of Biology, Chemistry and Pharmacy, Free University, Berlin 14195, Germany.
ORCID-Profile: Bernard Haendler
Zitieren
APA
Trun, W., Fernández-Montalván, A., Cao, Y. J., Haendler, B., & Zopf, D. (2025). Inhibition of EphB4 Receptor Signaling by Ephrin-B2-Competitive and Non-Competitive DARPins Prevents Angiogenesis. Biochemistry. https://doi.org/10.1021/acs.biochem.4c00431
Vancouver
Trun W, Fernández-Montalván A, Cao YJ, Haendler B, Zopf D. Inhibition of EphB4 Receptor Signaling by Ephrin-B2-Competitive and Non-Competitive DARPins Prevents Angiogenesis. Biochemistry. 2025. doi:10.1021/acs.biochem.4c00431
BibTeX
@article{Trun2025,
author = {Trun, Weronika and Fernández-Montalván, Amaury and Cao, Yong-Jiang and Haendler, Bernard and Zopf, Dieter},
title = {Inhibition of EphB4 Receptor Signaling by Ephrin-B2-Competitive and Non-Competitive DARPins Prevents Angiogenesis},
journal = {Biochemistry},
year = {2025},
doi = {10.1021/acs.biochem.4c00431}
}
EUVIMED